Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E2 release in the spinal cord

Journal of Neurochemistry

Volumn 79, Issue 4, 2001, Pages 777-786

  Tegeder, Irmgard ^a   Niederberger, Ellen ^a   Vetter, Gregor ^a   Bräutigam, Lutz ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Celecoxib; Cyclooxygenases; Microdialysis; Prostaglandin E2; Spinal cord

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FORMALDEHYDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; ENZYME INHIBITION; MICRODIALYSIS; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FORMALDEHYDE; ISOENZYMES; MEMBRANE PROTEINS; MICRODIALYSIS; PAIN; PAIN MEASUREMENT; POSTERIOR HORN CELLS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD; SULFONAMIDES;

ANIMALIA;

EID: 0035177677     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00613.x     Document Type: Article

References (53)

1. The formalin test: Scoring properties of the first and second phases of the pain response in rats
2. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
3. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis
4. Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord
5. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
6. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat
7. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: A c-Fos protein study in the rat spinal cord
8. Mechanical sensitization of cutaneous C-fiber nociceptors by prostaglandin E2 in the rat
9. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
10. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
11. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
12. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat
13. Peripheral analgesia: Mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists
14. Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamate
15. Proceedings: The concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin
16. Celecoxib, a COX-2-specific inhibitor: The clinical data
17. Spinal actions of cyclooxygenase isozyme inhibitors. Proceedings of the 9th World Congress on Pain
18. Antinociceptive actions of R(-)-flurbiprofen - A noncyclooxygenase inhibiting 2-arylpropionic acid - In rats
19. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: A microdialysis study
20. Kinetic basis for selective inhibition of cyclo-oxygenases
21. Prostaglandin release and altered microvascular integrity after burn injury
22. Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord
23. Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation: An in situ hybridization study
24. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects
25. Localization and regulation of cyclo-oxygenase-1 and-2 and neuronal nitric oxide synthase in mouse spinal cord
26. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat
27. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction
28. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test
29. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: A microdialysis study in unanesthetized rats
30. The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats
31. Effects of prostaglandin E2 and capsaicin on behavior and cerebrospinal fluid amino acid concentrations of unanesthetized rats: A microdialysis study
32. Allodynia evoked by intrathecal administration of prostaglandin F2 alpha to conscious mice
33. Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2 alpha injected into conscious mice
34. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice
35. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2
36. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation
37. Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons
38. Role of cyclooxygenase 2 in acute spinal cord injury
39. Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection
40. Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2
41. Peripheral noxious stimulation releases spinal PGE2 during the first phase in the formalin assay of the rat
42. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: A double blind investigation
43. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
44. Pharmacological analysis of cyclooxygenase-1 in inflammation
45. Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A
46. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration
47. Inhibition of NF-(kappa) B and AP-1 activation by R- and S-flurbiprofen
48. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice
49. Towards a better aspirin
50. Inflammation and the mechanism of action of anti-inflammatory drugs
51. New insights into the mode of action of anti-inflammatory drugs
52. Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation
53. The spinal biology in humans and animals of pain states generated by persistent small afferent input